Brain research bulletin

Shouhui Tongbian Capsule linked to antidepressant-like effects and gut-brain improvements in depressed mice

Updated

Abstract

SHTB administration was associated with significant improvements in depressive- and anxiety-like behaviors in mouse models.

  • Exploratory analysis suggested potential links between SHTB constituents and gene networks related to depression.
  • In mouse models, SHTB treatment reduced neuroinflammatory responses.
  • Hippocampal neuronal and synaptic integrity were preserved following SHTB administration.
  • Intestinal barrier function was maintained in mice treated with SHTB.
  • Changes in the expression of several neurotransmitter-related genes in the hippocampus were observed following treatment.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of Competing Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The funder, Lunan HOPE Pharmaceutical Co., Ltd., provided the SHTB capsules but had no role in the study design, data collection, analysis, interpretation, or decision to publish.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free